Attached files
file | filename |
---|---|
EX-21.1 - EXHIBIT 21.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x21_102909.htm |
EX-31.1 - EXHIBIT 31.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x311_102909.htm |
EX-31.2 - EXHIBIT 31.1 - Sunshine Biopharma, Inc | mtnwstbus10k73109x312_102909.htm |
10-K - ANNUAL REPORT FOR YEAR ENDED JULY 31, 2009 - Sunshine Biopharma, Inc | mtnwstbus10k73109_102909.htm |
Exhibit
32.1
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT 0F 2002
In
connection with the Annual Report of Mountain West Business Solutions, Inc.(the
Company") on Form 10-K for the period ended herein as filed with the Securities
and Exchange Commission (the "Report"), I. Matthew Milonas, Chief Executive and
Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350,
as adopted pursuant to ss.906 of the Sarbanes-Oxley Act of 2002,
that:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fully presents, in all material respects,
the financial condition and results of operations or the Company.
Dated:
October 29, 2009
By:
|
/s/ Matthew
Milonas
|
||
Matthew
Milonas
Chief
Executive Officer
Chief
Financial Officer
|
|||